RecruitingNCT05994976

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers for Molecular Characterization of Inflammatory Skin Diseases

Sponsor

Innovaderm Research Inc.

Enrollment

500 participants

Start Date

Oct 17, 2023

Study Type

OBSERVATIONAL

Conditions

Atopic Dermatitis Hidradenitis Suppurativa Acne Plaque Psoriasis Chronic Hand Eczema Palmoplantar Pustulosis

Summary

The purpose of the study is to collect different samples for molecular characterization of inflammatory skin diseases.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Blood samples collection, a procedure called Drainage fluid samples collection, and others for people with acne, atopic dermatitis, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBlood samples collection

biomarkers and optional genetic analysis

PROCEDUREOral samples collection

biomarkers analysis

PROCEDUREHair samples collection

biomarkers analysis

PROCEDURESkin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)

biomarkers analysis

PROCEDURESkin surface material samples

biomarkers analysis

PROCEDUREDrainage fluid samples collection

biomarkers analysis

PROCEDUREStool samples collection

biomarkers analysis

Locations(1)

Innovaderm Research Inc.

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05994976

Related Trials

Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

NCT072629831 location

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

NCT07116967394 locations

Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

NCT068992041 location

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

NCT0680728137 locations

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

NCT065643895 locations